查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621540

轉染技術市場：按產品、方法、技術、應用和最終用戶分類 - 2025-2030 年全球預測

Transfection Technologies Market by Product (Instrument, Reagent & Kits), Method (Cationic Lipid Transfection, Cotransfection, Electroporation), Technology, Applications, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年轉染技術市值為12.2億美元，預計2024年將達到13.5億美元，複合年成長率為9.97%，到2030年將達到23.9億美元。

轉染技術包括多種用於將核酸引入真核細胞並促進基因表現、基因靜默和基因組編輯的方法。這些技術的需求在於它們在藥物發現、基因研究和治療開發中的關鍵作用，使其成為分子生物學、遺傳學和生物醫學研究的寶貴工具。應用範圍包括基因表現研究、蛋白質生產和基因療法開發，最終用途是製藥、學術研究機構和生物技術公司。關鍵的成長要素包括生物分子結構的進步、基因治療和細胞研究資金籌措的增加以及對合成生物學應用的需求的增加。最近的潛在商機在於CRISPR技術的增強、非病毒轉染方法的開發、難以轉染的細胞的轉染以及公司應透過策略性投資和研究合作來瞄準的新興機會。然而，諸如高成本、某些試劑的細胞毒性以及原代細胞和體內條件下的遞送效率差等挑戰對市場成長構成了主要限制。智慧財產權問題和嚴格的法律規範使市場動態更加複雜。創新應著重於提高轉染效率、最大限度地減少細胞毒性、開發新型遞送載體以及整合人工智慧來預測和最佳化轉染結果。此外，基於生物分解性聚合物和奈米技術的輸送系統的探索代表了潛在的成長途徑。儘管市場競爭依然激烈，主導企業已站穩腳跟，但憑藉創新解決方案的新興企業也有空間在市場上開拓重要的利基市場。總體而言，與技術進步和監管發展保持一致，採用全面的品質保證，並加強對最終用戶的教育和支援服務將有助於利用轉染技術市場的有希望的成長軌跡。

主要市場統計
基準年[2023] 12.2億美元
預測年份 [2024] 13.5億美元
預測年份 [2030] 23.9億美元
複合年成長率（%） 9.97%

市場動態：揭示快速發展的轉染技術市場的關鍵市場洞察

供需的動態交互作用正在改變轉染技術市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 對個人化醫療和生物製藥的需求不斷成長
    • 開發新型非病毒傳遞系統並擴大商業性治療應用的製程規模
    • 增加公共和私人資金用於轉染技術的研究和開發
  • 市場限制因素
    • 先進轉染技術及相關產品成本相對較高
  • 市場機會
    • 隨著mRNA疫苗開發的不斷進展，需要一個能夠大規模生產的強大轉染系統。
    • 為特定細胞類型和應用開發多功能且可客製化的轉染試劑和設備
  • 市場挑戰
    • 對基因療法產品和轉染技術的嚴格監管要求

波特五力：駕馭轉染技術市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解轉染技術市場的外部影響

外部宏觀環境因素在塑造轉染技術市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解轉染技術市場的競爭格局

轉染技術市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質轉染技術市場供應商績效評估

FPNV定位矩陣是評估轉染技術市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定轉染技術市場成功之路的策略分析與建議

對於旨在加強其在全球市場的影響力的公司來說，對轉染技術市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對個人化醫療和生物製藥的需求不斷成長
      • 開發新型非病毒傳遞系統並擴大商業治療應用的製程規模
      • 增加公共和私人資金用於轉染技術的研究和開發
    • 抑制因素
      • 先進轉染技術及相關產品成本相對較高
    • 機會
      • mRNA疫苗的持續開發需要強大的轉染系統來滿足大規模生產的需求。
      • 為特定細胞類型和應用開發多功能且可客製化的轉染試劑和設備
    • 任務
      • 基因治療產品和轉染技術的嚴格監管要求
  • 市場區隔分析
    • 方法：由於成本效益，基於試劑的方法的重要性日益增加
    • 應用：蛋白質生產在生物製藥開發的多種應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章轉染技術市場：依產品

  • 裝置
  • 試劑和套件

第7章轉染技術市場：依方法

  • 陽離子脂質轉染
  • 共轉染
  • 電穿孔
  • 體內轉染
  • 脂轉染
  • 核轉染

第8章轉染技術市場：依技術分類

  • 基於生物化學的轉染
  • 物理轉染
  • 基於病毒載體的轉染

第9章轉染技術市場：依應用分類

  • 生物醫學研究
  • 基因靜默
  • 蛋白質生產
  • 穩定細胞株的產生
  • 幹細胞重編程和分化
  • 實施治療
  • 病毒生產

第10章轉染技術市場：依最終用戶分類

  • 學術研究所
  • 合約調查機構
  • 製藥和生物技術公司

第11章美洲轉染技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太轉染技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲轉染技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Polyplus 推出 FectoVIR-LV 轉染試劑以及新的 DOE 服務選項
    • BioCentriq 和 Kytopen 擴大合作夥伴關係，以加速創新基因編輯技術對細胞治療製造的影響
    • Avectus 宣布推出 Solpore 平台，用於下一代基因工程細胞療法的臨床製造，具有無與倫比的細胞健康和功能
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Akron Biotech
  • Altogen Biosystems
  • Bio-Rad Laboratories, Inc.
  • Biomol GmbH
  • Epoch Life Science
  • F. Hoffmann-La Roche AG
  • FUJIFILM Wako Pure Chemical Corporation
  • Geno Technology, Inc.
  • Lonza Group
  • Maxcyte Inc.
  • Merck KGaA
  • Mirus Bio
  • OriGene Technologies, Inc.
  • OZ Biosciences SAS
  • Polyplus-transfection SA by Sartorius AG
  • Polysciences, Inc.
  • Promega Corporation
  • Qiagen NV
  • Reprocell Inc.
  • SignaGen Laboratories
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC by Avantor
Product Code: MRR-B16853779807

The Transfection Technologies Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.35 billion in 2024, and is projected to grow at a CAGR of 9.97%, to USD 2.39 billion by 2030.

Transfection technologies encompass a range of methods used to introduce nucleic acids into eukaryotic cells, facilitating gene expression, gene silencing, or genome editing. The necessity of these technologies lies in their critical role in drug discovery, genetic research, and therapeutic development, making them invaluable tools in molecular biology, genetics, and biomedical research. Applications span across gene expression studies, protein production, and development of gene therapies, with significant end-use in pharmaceuticals, academic research institutions, and biotechnology firms. Key growth influences include advancements in biomolecular structures, increased funding in gene therapy and cell-based research, and rising demand for synthetic biology applications. Recent potential opportunities lie in CRISPR technology enhancements, development of non-viral transfection methods, and transfection in difficult-to-transfect cells, representing emerging markets that companies should target through strategic investments and collaborations. However, challenges such as high costs, cytotoxicity of certain reagents, and delivery inefficiency in primary cells or in vivo conditions pose significant limitations to market growth. Intellectual property issues and stringent regulatory frameworks further complicate market dynamics. Innovation should focus on enhancing transfection efficiency, minimizing cytotoxicity, developing novel delivery vectors, and integrating AI to predict and optimize transfection outcomes. Additionally, exploring biodegradable polymers and nanotechnology-based delivery systems presents potential growth avenues. The market nature remains competitive with strong footholds of dominant players yet offers space for novel and emerging companies equipped with innovative solutions to carve out significant market niches. Overall, aligning with technological advancements and regulatory developments, adopting comprehensive quality assurance, and enhancing educational and support services for end users will be crucial in capitalizing on the promising growth trajectory of the transfection technologies market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.35 billion
Forecast Year [2030] USD 2.39 billion
CAGR (%) 9.97%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transfection Technologies Market

The Transfection Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for personalized medicine and biopharmaceuticals
    • Development of novel, non-viral delivery systems and scaling up processes for commercial therapeutic applications
    • Increased public and private funding for research and development in transfection technologies
  • Market Restraints
    • Relatively high cost of advanced transfection technologies and related products
  • Market Opportunities
    • Ongoing development of mRNA vaccines necessitated robust transfection systems capable for large-scale production needs
    • Development of versatile and customizable transfection reagents and equipment tailored for specific cell types and applications
  • Market Challenges
    • Stringent regulatory requirements for gene therapy products and transfection technologies

Porter's Five Forces: A Strategic Tool for Navigating the Transfection Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transfection Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transfection Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transfection Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transfection Technologies Market

A detailed market share analysis in the Transfection Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transfection Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transfection Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transfection Technologies Market

A strategic analysis of the Transfection Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transfection Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Akron Biotech, Altogen Biosystems, Bio-Rad Laboratories, Inc., Biomol GmbH, Epoch Life Science, F. Hoffmann-La Roche AG, FUJIFILM Wako Pure Chemical Corporation, Geno Technology, Inc., Lonza Group, Maxcyte Inc., Merck KGaA, Mirus Bio, OriGene Technologies, Inc., OZ Biosciences SAS, Polyplus-transfection SA by Sartorius AG, Polysciences, Inc., Promega Corporation, Qiagen NV, Reprocell Inc., SignaGen Laboratories, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor.

Market Segmentation & Coverage

This research report categorizes the Transfection Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instrument and Reagent & Kits.
  • Based on Method, market is studied across Cationic Lipid Transfection, Cotransfection, Electroporation, In Vivo Transfection, Lipofection, and Nucleofection.
  • Based on Technology, market is studied across Biochemical Based Transfection, Physical Transfection, and Viral-Vector Based Transfection.
  • Based on Applications, market is studied across Bio-Medical Research, Gene Silencing, Protein Production, Stable Cell Line Generation, Stem Cell Reprogramming & Differentiation, Therapeutic Delivery, and Virus Production.
  • Based on End-user, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for personalized medicine and biopharmaceuticals
      • 5.1.1.2. Development of novel, non-viral delivery systems and scaling up processes for commercial therapeutic applications
      • 5.1.1.3. Increased public and private funding for research and development in transfection technologies
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of advanced transfection technologies and related products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of mRNA vaccines necessitated robust transfection systems capable for large-scale production needs
      • 5.1.3.2. Development of versatile and customizable transfection reagents and equipment tailored for specific cell types and applications
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements for gene therapy products and transfection technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Method: Rising significance of reagent-based methods due to cost effectiveness
    • 5.2.2. Application: Diverse applications in protein production in biopharmaceutical development
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transfection Technologies Market, by Product

  • 6.1. Introduction
  • 6.2. Instrument
  • 6.3. Reagent & Kits

7. Transfection Technologies Market, by Method

  • 7.1. Introduction
  • 7.2. Cationic Lipid Transfection
  • 7.3. Cotransfection
  • 7.4. Electroporation
  • 7.5. In Vivo Transfection
  • 7.6. Lipofection
  • 7.7. Nucleofection

8. Transfection Technologies Market, by Technology

  • 8.1. Introduction
  • 8.2. Biochemical Based Transfection
  • 8.3. Physical Transfection
  • 8.4. Viral-Vector Based Transfection

9. Transfection Technologies Market, by Applications

  • 9.1. Introduction
  • 9.2. Bio-Medical Research
  • 9.3. Gene Silencing
  • 9.4. Protein Production
  • 9.5. Stable Cell Line Generation
  • 9.6. Stem Cell Reprogramming & Differentiation
  • 9.7. Therapeutic Delivery
  • 9.8. Virus Production

10. Transfection Technologies Market, by End-user

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Transfection Technologies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Transfection Technologies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Transfection Technologies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
    • 14.3.2. BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
    • 14.3.3. Avectas Launches the Solupore Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Akron Biotech
  • 3. Altogen Biosystems
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biomol GmbH
  • 6. Epoch Life Science
  • 7. F. Hoffmann-La Roche AG
  • 8. FUJIFILM Wako Pure Chemical Corporation
  • 9. Geno Technology, Inc.
  • 10. Lonza Group
  • 11. Maxcyte Inc.
  • 12. Merck KGaA
  • 13. Mirus Bio
  • 14. OriGene Technologies, Inc.
  • 15. OZ Biosciences SAS
  • 16. Polyplus-transfection SA by Sartorius AG
  • 17. Polysciences, Inc.
  • 18. Promega Corporation
  • 19. Qiagen NV
  • 20. Reprocell Inc.
  • 21. SignaGen Laboratories
  • 22. Takara Bio Inc.
  • 23. Thermo Fisher Scientific, Inc.
  • 24. VWR International, LLC by Avantor

LIST OF FIGURES

  • FIGURE 1. TRANSFECTION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSFECTION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSFECTION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSFECTION TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REAGENT & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CATIONIC LIPID TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COTRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY IN VIVO TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY LIPOFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY NUCLEOFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOCHEMICAL BASED TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRAL-VECTOR BASED TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIO-MEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY GENE SILENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STABLE CELL LINE GENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STEM CELL REPROGRAMMING & DIFFERENTIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRUS PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 243. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023